Skip to content

Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy

Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06114160
Acronym
Coqueluche-Vac
Enrollment
500
Registered
2023-11-02
Start date
2023-12-01
Completion date
2024-05-01
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Keywords

cocooning strategy, pertussis, pregnancy, vaccination against pertussis

Brief summary

In France, it has been recommended since 2022 that pregnant women be vaccinated against pertussis from 20 to 36 weeks' gestation. This vaccination schedule is inspired by the Anglo-Saxon model and studies showing the effectiveness of this practice. The aim of this vaccine is to protect the newborn by transferring antibodies from the fetus to the placenta, because Pertussis is a particularly serious disease in newborns.

Detailed description

The aim is to describe pregnant women's knowledge concerning pertussis, vaccination against pertussis during pregnancy and the cocooning strategy.

Interventions

OTHERData collection

Data collection

Sponsors

Université de Reims Champagne-Ardenne
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant between 20 and 41 weeks of amenorrhea * Primiparous * aged more than 18 * Agreed to participate in the study

Exclusion criteria

* Multiparous * Protected by law (guardianship, guardianship, safeguarding of justice) * Not agreed to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
recommendation of vaccination against pertussisday0Knowledge of pregnant women's concerning recommendation of vaccination against pertussis from 20 to 36 weeks' gestation : does the woman know or not the recommandation concerning the vaccination

Contacts

Primary ContactBarbe Coralie, DR
coralie.barbe@univ-reims.fr0326913665
Backup ContactCURRS CURRS
curss@univ-reims.fr0326918822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026